Enliven Therapeutics, Inc.

NASDAQ:ELVN

20.74 (USD) • At close June 6, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2025 Q12024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q1
Operating Activities:
Net Income -28.544-23.18-23.156-19.95-22.738-19.37-20.769-16.721-14.72432.185-10.554-8.889-8.669-8.392-13.647-13.161-10.257-11.518-12.423-10.204-7.215-7.25-6.622-5.397-4.194
Depreciation & Amortization 0.0290.080.080.0780.0790.0770.0780.0740.0670.0640.060.0520.0390.0330.0240.0250.0250.0230.0250.0250.0240.0250.00800
Deferred Income Tax 00000-4.17100-1.904-0.6211.721-0.030000000000000
Stock Based Compensation 6.7995.3395.1765.1444.5153.0563.4014.1952.2620.7351.1010.7010.6540.6171.0030.9170.9470.6790.6420.550.360.2970.310.1970.095
Change In Working Capital 0-0.515.052-4.384-4.6355.4643.1521.234-8.4490.2821.2051.012-2.3851.1481.7021.823-3.792.3681.4590.386-2.701-1.1010.030.0521.692
Accounts Receivables 0000000000000000000000000
Change In Inventory 0000000000000000000000000
Change In Accounts Payables 0.220.323-0.064-1.6042.155-0.961-1.593-0.1880.492-0.621.3580.592-1.5570.481-0.15-0.3751.030.0850.34-0.2910.179-0.8390.825-0.1670.931
Other Working Capital 0-0.8335.116-2.78-6.796.4254.7451.422-8.9410.902-0.1530.42-0.8280.6671.8522.198-4.822.2831.1190.677-2.88-0.262-0.7950.2190.761
Other Non Cash Items 01.0680.655-1.3231.9362.462-1.756-0.8311.904-34.5250.020.031.631.1961.2181.3730.0220.179-0.049-0.0130.005-0.013-0.00600
Operating Cash Flow -24.127-17.203-12.193-20.435-23.361-12.482-15.894-12.049-20.844-1.88-6.447-7.124-10.361-6.594-10.901-10.365-13.02-8.269-10.346-9.256-9.527-8.042-6.28-5.148-2.407
Investing Activities:
Investments In Property Plant And Equipment -0.020-0.022-0.002-0.02-0.014-0.016-0.088-0.031-0.101-0.014-0.303-0.194-0.05700-0.0120.0040-0.007-0.0150-0.059-0.0810
Acquisitions Net 0000040-400035000000000000000
Purchases Of Investments -59.225-116.515-234.225-120.829-56.778-41.3-75.533-151.430-35000-17.791-22.232-3.812-3.722-8.392-13.98200-2.112-21.80800
Sales Maturities Of Investments 60.672117.242196.67277.16638.9138040006.8223.1056.4835.473.313.47.222.03729.63.79.4284.7720000
Other Investing Activites 000.85110-17.8650.03940-0.151035.101-23.105-6.483-5.47000000-41.82900000
Investing Cash Flow 1.4270.727-36.724-33.665-17.88538.686-35.549-151.518-0.03141.82-0.014-0.303-0.194-0.057-8.8323.38818.30321.212-10.282-32.4084.757-2.112-21.867-0.0810
Financing Activities:
Debt Repayment 0000000000000000000000000
Common Stock Issued 0-50.50789.695-0.305900.09-0.425-1.504163.04-1.2330000.00246.9911.660.460.5970.1359.59386.5560000
Common Stock Repurchased 000.320000000000000000000000
Dividends Paid 0000000000000000000000000
Other Financing Activities 0.23490.4791.1171.8060.270.09-0.425-2.82237.441-2.3770.1640.0050.409-1.4790000000-1.99601.64843.927
Financing Cash Flow 0.23439.9721.1171.80690.270.09-0.425-2.82237.441-1.2330.1640.0050.409-1.47746.9911.660.460.5970.1359.59386.556-1.99601.64843.927
Other Information:
Effect Of Forex Changes On Cash 000000.054000-38.71825.181.3710000000000000
Net Change In Cash -22.46623.4963.75-52.29449.02426.348-51.868-166.387216.56638.707-6.297-7.422-10.146-8.12827.083-5.4925.65513.54-20.493-32.07181.786-12.15-28.147-3.58141.52
Cash At End Of Period 101.705124.171100.67596.925149.219100.19573.901125.769292.15688.19886.21392.5199.932110.07875.29548.03753.44147.78634.24654.73986.815.02417.17445.32148.902